AzTrials
AzTrials

AgingNEUROAGENCT01481246

Neurocognitive Study for the Aging-a Longitudinal Study With a Greek Cypriot Cohort

An observational study of Aging and Memory Impairment, run by University of Cyprus at 1 site in Cyprus.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The Neurocognitive Study for the Aging (NEUROAGE) was initially funded by the Cyprus Innovation Foundation and has received subsequent funding by the European Union Regional Development Fund. Read more about this study

Who is it for?
Ages 60 to 90 yearsHealthy volunteers can take part
Conditions the study is for
Aging, Memory Impairment, Cognitive Decline
What is being tested?
Categorization training and Psychosocial and Psychoeducational Group training
How many people
1,000 participants
Where
1 siteCyprus
Study dates
Jul 2009to Dec 2025
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 60 to 90 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: Normal older adults and adults with cognitive decline are recruited in this study

Who may be able to join

  • healthy with no prior neurological history

Who cannot join

  • prior neurological history or significant psychiatric history

Trial locations and contacts

1 site in 1 country.

Fofi Constantinidou, Ph.D. contact

35722892078

fofic@ucy.ac.cy

Cyprus1 site, 1 recruiting
  • University of Cyprus

    Nicosia, 1678

    Fofi Constantinidou, Ph.D., 35722894437, fofic@ucy.ac.cy

    Fofi Constantinidou, Ph.D.

    Recruiting

Other trials in Cyprus

About this study

Official title: The Neurocognitive Study for the Aging

The Neurocognitive Study for the Aging (NEUROAGE) was initially funded by the Cyprus Innovation Foundation and has received subsequent funding by the European Union Regional Development Fund. The project focuses on the understanding of the effects of age on neurocognitive abilities such as attention, memory, language, categorization, and executive functioning. In addition, specific arms of the project investigate the effects of a theory-driven hierarchical training program, the Categorization Program, to improve cognitive abilities in adults with Mild Cognitive Impairment (MCI) and of a group intervention program focusing on cognitive and psychosocial abilities. Over 1000 adults ages 40 and older have been recruited in the NEUROAGE project thus far. The grant was awarded to the University of Cyprus, with Professor Fofi Constantinidou as the PI.

Read the detailed description

Given the fact that older adults are expected to live longer while maintaining their social and professional activities, the development of effective cognitive retraining methodologies designed to maximize independence has been of interest. In addition to changes caused by the normal aging process, older adults over 65 are at a high risk for developing dementia. About 8-12% of the older adult population will demonstrate a pre-dementia syndrome referred to as Mild Cognitive Impairment (MCI) which is considered a prodrome to dementia. Consequently, it is important to identify variables that contribute to the development of MCI as well as neurocognitive therapy approaches to help patients improve their level of functioning.

Categorization is one of the most fundamental cognitive processes. The ability to divide the world into discrete categories is a rudimentary process beginning early in life and continues to be developed and refined across the lifespan. This underlying process is crucial to a variety of neurocognitive abilities including attention and memory and can influence vocational and educational reintegration. Normal aging results in categorization deficits which in turn can interfere with the individual's ability to attend, remember, and organize information. This difficulty could hamper activities of daily living, social participation, and independence. This project implements an innovative treatment program based on current theoretical models of human cognition designed to improve neurocognitive abilities.

One of the objectives of the project is to provide evidence on the effectiveness of a systematic and hierarchical neurocognitive therapy method, the Categorization Program (CP) in adults with MCI and in normal older adults. It is hypothesized that the CP will be an effective treatment approach to improve categorization abilities in both groups of subjects. In addition, since 2020, we have been implementing a group intervention program as part of our recent funding to investigate its feasibility in healthy older adults and in adults with MCI.

The following activities have been taking place:

  1. Initially, a population-based sample of 500 older adults was tested using a battery of neuropsychological measures. Normal older adults are reassessed every two years. Currently, more than 800 healthy adults have been recruited in this project.
  2. Second, normal OA and adults with MCI have been randomly assigned into either the treated or untreated groups. The treated groups receive the CP training in order to test its effectiveness.
  3. Third, the long term effects of cognitive retraining is being assessed.
  4. Finally, the project examines the relationship between the categorization tasks, neuropsychological performance, functional outcome measures, and subject characteristics including health indices, education, and biomarkers. Theoretical constructs such as Cognitive Reserve have been explored as part of this project.

The long-term objective of this research program is to determine variables that influence cognitive decline in older adults and develop effective neurocognitive therapy techniques.

Being tested
Categorization training, Psychosocial and Psychoeducational Group training
Keywords
neurorehabilitation, cognition, aging, MCI, cognitive decline
Medical subject headings
Memory Disorders, Cognitive Dysfunction, Neurocognitive Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Categorization trainingBehavioural

    Behavioral intervention consisting of cognitive training exercises to improve categorization performance

  • Psychosocial and Psychoeducational Group trainingBehavioural

    Group treatment with a focus on psychosocial and psychoeducational intervention in healthy adults and in adults with cognitive decline. Ten week cycle, 2 hours per week group intervention study.

Study groups in NCT01481246
Study groupRoleWhat they receive
Normal Aging/Cognitive DeclineHealth adults as well as adults with MCI and early stage AD are being recruited in the study
Receives: Behavioral: Categorization training; Behavioral: Psychosocial and Psychoeducational Group training

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Neuropsychological Tests

    a variety of cognitive tests as well as psychosocial measures are used in this project

    Measured: on going

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted29 Nov 2011 (estimated)
  2. Study startJul 2009
  3. Primary completionDec 2025 (estimated)
  4. Study completionDec 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
1,000 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01481246
Sponsor's protocol ID
Humanities/Society/0308(ΒΕ)/07
Other IDs
Humanities/Society/0308(ΒΕ)/07, SKEPSH, EXCELLENCE/1216/0404
Acronym
NEUROAGE
Status last verified
Aug 2023
First submitted
25 Nov 2011
Last updated
22 Aug 2023
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Chadjikyprianou A, Constantinidou F. Effectiveness of a Novel Multidimensional Group Intervention to Enhance Subjective Cognitive and Psychosocial Functioning in Healthy Older Adults. J Aging Health. 2025 Oct 24:8982643251391224. doi: 10.1177/08982643251391224. Online ahead of print.

    PubMed 41135181
  • Chadjikyprianou A, Constantinidou F. A new multidimensional group intervention for cognitive and psychosocial functioning for older adults: Background, content, and process evaluation. Front Med (Lausanne). 2023 Apr 20;10:1161060. doi: 10.3389/fmed.2023.1161060. eCollection 2023.

    PubMed 37153102

Questions about this trial

What is this clinical trial studying?

An observational study of Aging and Memory Impairment, run by University of Cyprus at 1 site in Cyprus.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 22 Aug 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Cyprus. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Fofi Constantinidou, Ph.D. (35722892078, fofic@ucy.ac.cy), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Neuropsychological Tests (time frame: on going). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT01481246, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Aug 2023; AzTrials last refreshed its copy on 27 Oct 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in